These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 33757805)
21. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination. Dang YL; Bryson A BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848426 [TBL] [Abstract][Full Text] [Related]
22. Bhutan's COVID-19 Vaccination Efforts and the Evolution of COVID-19 Cases in the Aftermath. Gyeltshen D; Dema T; Ahmadi A; Lucero-Prisno DE Asia Pac J Public Health; 2022 Jan; 34(1):125-127. PubMed ID: 34670431 [TBL] [Abstract][Full Text] [Related]
23. An extraordinary wave of SARS-CoV2, the youngest and the least serious. Justribó E; Falcon A; Ruiz-Vert MJ; Porque J; Gros S; Yuguero O Front Public Health; 2023; 11():1238045. PubMed ID: 37965504 [TBL] [Abstract][Full Text] [Related]
24. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases. Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721 [TBL] [Abstract][Full Text] [Related]
25. [SARS-CoV-2 infection and COVID‒19 in Gaucher disease: indications for vaccination]. Maródi L Orv Hetil; 2021 Jun; 162(24):938-942. PubMed ID: 34120104 [TBL] [Abstract][Full Text] [Related]
26. Perniosis-like erythema after SARS-CoV2 infection reactivated by vaccination with inactivated virus. Campos Garcia L; Barcelos VM; Macedo de Alcântara M; Valadares PJC An Bras Dermatol; 2023; 98(4):552-554. PubMed ID: 37003902 [No Abstract] [Full Text] [Related]
27. Detection of environmental SARS-CoV-2 RNA in a high prevalence setting in Spain. Fernández-de-Mera IG; Rodríguez Del-Río FJ; de la Fuente J; Pérez-Sancho M; Hervás D; Moreno I; Domínguez M; Domínguez L; Gortázar C Transbound Emerg Dis; 2021 May; 68(3):1487-1492. PubMed ID: 32894654 [TBL] [Abstract][Full Text] [Related]
28. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. Pavoni V; Gianesello L J Thromb Thrombolysis; 2021 May; 51(4):1111-1112. PubMed ID: 33057907 [No Abstract] [Full Text] [Related]
29. Impact of COVID-19 pandemic on hepatitis C elimination from the clinical microbiologist perspective. Are we ready? Aguilera A; Eiros JM; García F Enferm Infecc Microbiol Clin (Engl Ed); 2021 Nov; 39(9):475-476. PubMed ID: 34454863 [No Abstract] [Full Text] [Related]
30. The COVID-19 Pandemic in Spain: Experiences of Midwives on the Healthcare Frontline. Goberna-Tricas J; Biurrun-Garrido A; Perelló-Iñiguez C; Rodríguez-Garrido P Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34204286 [TBL] [Abstract][Full Text] [Related]
31. Is HCV elimination possible in prison? Crespo J; Llerena S; Cobo C; Cabezas J Rev Esp Sanid Penit; 2017 Dec; 19(3):70-73. PubMed ID: 29364331 [No Abstract] [Full Text] [Related]
32. Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking. Elghoneimy LK; Ismail MI; Boeckler FM; Azzazy HME; Ibrahim TM Comput Biol Med; 2021 Jul; 134():104468. PubMed ID: 34015671 [TBL] [Abstract][Full Text] [Related]
33. Public healthcare expenditure and COVID-19 mortality in Spain and in Europe. Response to the Letter from the Editor by Velasco Montes et al. Elola-Somoza FJ; Bas-Villalobos MC; Pérez-Villacastín J; Macaya-Miguel C Rev Clin Esp (Barc); 2022 Jan; 222(1):56-57. PubMed ID: 34799280 [No Abstract] [Full Text] [Related]
34. On public healthcare expenditure and COVID-19 mortality in Spain and in Europe. Velasco Montes J; González Díez S; Rivas Cilleros E Rev Clin Esp (Barc); 2022 Jan; 222(1):56. PubMed ID: 34799279 [No Abstract] [Full Text] [Related]
35. Altered hepatitis C testing and treatment beyond the COVID-19 pandemic. Karimi-Sari H; Rezaee-Zavareh MS Public Health; 2022 Jun; 207():e5. PubMed ID: 35568527 [No Abstract] [Full Text] [Related]
36. New-onset Evans syndrome in a patient with SLE post SARS-CoV2 mRNA vaccination. Ng TYM; Teo WZY; Ng TYM; Teng GG Ann Hematol; 2023 Jan; 102(1):235-236. PubMed ID: 36369498 [No Abstract] [Full Text] [Related]
37. [Planning and significance of tests to confrim the presence of anti-hepatitis-C antibodies in blood donors. Spanish Study Group for Blood Donors at Risk]. León P; Echevarría JM Sangre (Barc); 1999 Oct; 44(5):309-14. PubMed ID: 10618905 [No Abstract] [Full Text] [Related]
38. Severe coronary artery spasm after administration of a 5-hydroxytryptamine type 1 receptor agonist and SARS-CoV2 vaccination: Comment. Kleebayoon A; Wiwanitkit V Acta Cardiol; 2023 Oct; 78(8):974. PubMed ID: 36729020 [No Abstract] [Full Text] [Related]
39. Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61.3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice. Turan RD; Tastan C; Dilek Kancagi D; Yurtsever B; Sir Karakus G; Ozer S; Abanuz S; Cakirsoy D; Tumentemur G; Demir S; Seyis U; Kuzay R; Elek M; Kocaoglu ME; Ertop G; Arbak S; Acikel Elmas M; Hemsinlioglu C; Hatirnaz Ng O; Akyoney S; Sahin I; Kayhan CK; Tokat F; Akpinar G; Kasap M; Kocagoz AS; Ozbek U; Telci D; Sahin F; Yalcin K; Ratip S; Ince U; Ovali E Sci Rep; 2021 Aug; 11(1):15799. PubMed ID: 34349145 [TBL] [Abstract][Full Text] [Related]
40. Acute-onset chronic inflammatory demyelinating polyneuropathy after COVID-19 infection and subsequent ChAdOx1 nCoV-19 vaccination. Suri V; Pandey S; Singh J; Jena A BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34607818 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]